These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10483340)

  • 21. The clinical utility of genetic information in the care of persons with Alzheimer's disease.
    Holston EC; Schutte DL
    Medsurg Nurs; 2004 Dec; 13(6):415-9. PubMed ID: 15714746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study of MICA and MICB in Alzheimer's disease.
    Quiroga I; Lehmann DJ; Barnardo MC; Fuggle S; Cortina-Borja M; Warden DR; Smith AD
    Tissue Antigens; 2009 Sep; 74(3):241-3. PubMed ID: 19691640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating a treatment effect from multidimensional longitudinal data.
    Gray SM; Brookmeyer R
    Biometrics; 1998 Sep; 54(3):976-88. PubMed ID: 9750246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing and Alzheimer's disease.
    Health News; 1998 Mar; 4(4):5. PubMed ID: 9553608
    [No Abstract]   [Full Text] [Related]  

  • 27. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.
    Ballard C; Massey H; Lamb H; Morris C
    J Neurol Neurosurg Psychiatry; 1997 Aug; 63(2):273-4. PubMed ID: 9285479
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of Alzheimer's disease patients with and without ApoE4 allele.
    Ritchie K; Kotzki PO; Touchon J; Cristol JP
    Lancet; 1996 Oct; 348(9032):960. PubMed ID: 8843827
    [No Abstract]   [Full Text] [Related]  

  • 29. Alzheimer's disease. Stages of cognitive decline.
    Reisberg B
    Am J Nurs; 1984 Feb; 84(2):225-8. PubMed ID: 6559541
    [No Abstract]   [Full Text] [Related]  

  • 30. Apolipoprotein E and Alzheimer disease.
    Growdon JH
    Arch Neurol; 1998 Aug; 55(8):1053-4. PubMed ID: 9708953
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular pathogenesis of Alzheimer's disease].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Sep; 38(5):617-8. PubMed ID: 11605204
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein E and cognitive decline in Alzheimer's disease.
    Plassman BL; Breitner JC
    Neurology; 1996 Aug; 47(2):317-20. PubMed ID: 8756999
    [No Abstract]   [Full Text] [Related]  

  • 33. Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.
    Schwarz F; Springer SA; Altheide TK; Varki NM; Gagneux P; Varki A
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):74-9. PubMed ID: 26621708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking, Alzheimer's disease, and confounding with genes.
    Plassman BL; Helms MJ; Welsh KA; Saunders AM; Breitner JC
    Lancet; 1995 Feb; 345(8946):387. PubMed ID: 7772122
    [No Abstract]   [Full Text] [Related]  

  • 35. APOE: a risk factor for multiple disorders.
    Myers AJ; Nemeroff CB
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):545-8. PubMed ID: 22627179
    [No Abstract]   [Full Text] [Related]  

  • 36. [Letter regarding the paper of K Czyzewski, A. Pffefer, M. Barcikowska published in N.Nch Pol., vol. 32, No. 1, pg. 125].
    Wehr H
    Neurol Neurochir Pol; 1998; 32(6):1605-6. PubMed ID: 10358849
    [No Abstract]   [Full Text] [Related]  

  • 37. Genomics: the next psychiatric revolution?
    Farmer A; Owen MJ
    Br J Psychiatry; 1996 Aug; 169(2):135-8. PubMed ID: 8871788
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary to cognitive and behavioral heterogeneity.
    Richard I; Kurlan R
    Neurobiol Aging; 2000; 21(6):863-4; discussion 875-7. PubMed ID: 11124430
    [No Abstract]   [Full Text] [Related]  

  • 39. The Alzheimer's-Eating Connection: A Socio-Cultural Perspective on Cognitive Health.
    Zhou Q; Chen J
    J Nutr; 2024 Sep; 154(9):2887. PubMed ID: 39019163
    [No Abstract]   [Full Text] [Related]  

  • 40. Search for Alzheimer's disease genes yields new candidates.
    Kolchinsky A
    Surg Neurol; 1999 Jul; 52(1):21. PubMed ID: 10390166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.